The Journal of Allergy and Clinical Immunology
Volume 121, Issue 3 , Pages 632-638.e2 , March 2008

Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center

  • Colin W. Summers, MSc

      Affiliations

    • Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • These authors contributed equally to this work.
    • ,
  • Richard S. Pumphrey, FRCPath

      Affiliations

    • Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • These authors contributed equally to this work.
    • ,
  • Charlotte N. Woods, MSc

      Affiliations

    • Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • Department of Clinical Biochemistry, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • ,
  • Garry McDowell, MRCPath, PhD

      Affiliations

    • Department of Clinical Biochemistry, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • ,
  • Philip W. Pemberton, MSc

      Affiliations

    • Department of Clinical Biochemistry, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • ,
  • Peter D. Arkwright, FRCPCH, DPhil

      Affiliations

    • Department of Immunology, University of Manchester, Manchester Royal Infirmary, Manchester, United Kingdom
    • Corresponding Author InformationReprint requests: Peter D. Arkwright, FRCPCH, DPhil, Senior Lecturer in Pediatric Immunology, University of Manchester, Department of Immunology, Manchester Royal Infirmary, Oxford Rd, Manchester, M13 9PL, United Kingdom.

Received 26 September 2007 ,Revised 4 December 2007 ,Accepted 5 December 2007.

References 

  1. Tariq SM, Stevens M, Matthews S, Ridout S, Twiselton R, Hide DW. Cohort study of peanut and tree nut sensitisation by age of 4 years. BMJ. 1996;313:514–517
  2. Grundy J, Matthews S, Bateman B, Dean T, Arshad SH. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J Allergy Clin Immunol. 2002;110:784–789
  3. Kagan RS, Joseph L, Dufresne C, Gray-Donald K, Turnbull E, Pierre YS, et al. Prevalence of peanut allergy in primary-school children in Montreal, Canada. J Allergy Clin Immunol. 2003;112:1223–1228
  4. Rona RJ, Keil T, Summers C, Gislason D, Zuidmeer L, Sodergren E, et al. The prevalence of food allergy: a meta-analysis. J Allergy Clin Immnol. 2007;120:638–646
  5. Sicherer SH, Sampson HA. Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol. 2007;120:491–503
  6. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327:380–384
  7. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107:191–193
  8. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp. 2004;257:116–128
  9. Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol. 2007;119:1018–1019
  10. Pumphrey R. Anaphylaxis: can we tell who is at risk of fatal reaction?. Curr Opin Allergy Clin Immunol. 2004;4:285–290
  11. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391–397
  12. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy. 2007;62:857–871
  13. Kaplan AP, Joseph K, Silverberg M. Pathways for bradykinin formation and inflammatory disease. J Allergy Clin Immunol. 2002;109:195–209
  14. Simmons WH, Orawski AT. Membrane bound aminopeptidase P from bovine lung: its purification, properties and degradation of bradykinin. J Biol Chem. 1992;267:4897–4903
  15. Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arc Dis Child. 2002;86:236–239
  16. Settipane GA. Anaphylactic deaths in asthmatic patients. Allergy Proc. 1989;10:271–274
  17. NHLBI Expert Panel Report 3. Guidelines for the diagnosis and management of asthma. 2007. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed October 15, 2007.
  18. Davoren M, Peake J. Cashew nut allergy is associated with a high risk of anaphylaxis. Arch Dis Child. 2005;90:1084–1085
  19. Clarke AT, Anagnostou K, Ewan PW. Cashew nut causes more severe reactions than peanut: case-matched comparison in 141 children. Allergy. 2007;62:913–916
  20. Hirschwehr R, Valenta R, Ebner C, Ferreira F, Sperr WR, Valent P, et al. Identification of common allergenic structures in hazel pollen and hazelnuts: a possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen. J Allergy Clin Immunol. 1992;90:927–936
  21. Radauer C, Breiteneder H. Evolutionary biology of plant food allergens. J Allergy Clin Immunol. 2007;120:518–525
  22. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angio-oedema. Lancet. 1998;351:1693–1697
  23. Blais C, Marceau F, Rouleau JL, Adam A. The kallikrein-kininogen system: lessons from the quantification of endogenous kinins. Peptides. 2000;21:1903–1940
  24. Slater EE, Merrill DD, Guess HA, Roylance PJ, Cooper WD, Inman WH, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA. 1988;260:967–970
  25. Adam A, Cugno M, Molinaro G, Perez M, Lepage Y, Agostoni A. Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. Lancet. 2002;359:2088–2089
  26. Kim KS, Kumar S, Simmons WH, Brown NJ. Inhibition of aminopeptidase P potentiates wheal response to bradykinin in angiotensin-converting enzyme inhibitor-treated humans. J Pharmacol Exp Ther. 2000;292:295–298
  27. Studdy PR, Lapworth R, Bird R. Angiotensin-converting enzyme and its clinical significance: a review. J Clin Pathol. 1983;36:938–947
  28. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197–205
  29. Duan QL, Nikpoor B, Dube MP, Molinaro G, Meijar IA, Dion P, et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet. 2005;77:617–626
  30. Bork K, Barnstedt SE. Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema. Arch Intern Med. 2001;161:714–718
  31. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol. 2007;119:1497–1503
  32. Clark AT, Ewan PW. Interpretation of tests for nut allergy in one thousand patients, in relation to allergy and tolerance. Clin Exp Allergy. 2003;33:1041–1045

 Supported by the Food Standards Agency.

 Disclosure of potential conflict of interest: R. S. Pumphrey has received research support from hospital endowment funds, the Anaphylaxis Campaign, and the Food Standards Agency; was employed by the National Health Service; and has served as an expert for Her Majesty's Coroners. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)02400-1

doi: 10.1016/j.jaci.2007.12.003

The Journal of Allergy and Clinical Immunology
Volume 121, Issue 3 , Pages 632-638.e2 , March 2008

Article Tools

* Image Usage & Resolution